These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31809217)

  • 21. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study.
    Stopka TJ; Estadt AT; Leichtling G; Schleicher JC; Mixson LS; Bresett J; Romo E; Dowd P; Walters SM; Young AM; Zule W; Friedmann PD; Go VF; Baker R; Fredericksen RJ
    Soc Sci Med; 2024 Apr; 346():116660. PubMed ID: 38484417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient's and healthcare provider's experiences with Opioid Maintenance Treatment (OMT): a qualitative evidence synthesis.
    Steiro A; Hestevik CH; Muller AE
    BMC Health Serv Res; 2024 Mar; 24(1):333. PubMed ID: 38481254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.
    Cao Y; Stewart K; Wish E; Artigiani E; Sorg MH
    J Subst Abuse Treat; 2019 Jun; 101():55-66. PubMed ID: 31174714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians.
    Stöver H
    Eur Addict Res; 2011; 17(1):44-54. PubMed ID: 20975276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment.
    Pielech M; Modrowski C; Yeh J; Clark MA; Marshall BDL; Beaudoin FL; Becker SJ; Miranda R
    Addict Sci Clin Pract; 2024 Mar; 19(1):20. PubMed ID: 38515214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America.
    Cole ES; DiDomenico E; Green S; Heil SKR; Hilliard T; Mossburg SE; Sussman AL; Warwick J; Westfall JM; Zittleman L; Salvador JG
    Subst Abus; 2021; 42(2):123-129. PubMed ID: 33689594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparities Between US Opioid Overdose Deaths and Treatment Capacity: A Geospatial and Descriptive Analysis.
    Langabeer JR; Gourishankar A; Chambers KA; Giri S; Madu R; Champagne-Langabeer T
    J Addict Med; 2019; 13(6):476-482. PubMed ID: 30844879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving methadone access for rural communities in the USA: lessons learned from COVID-19 adaptations and international models of care.
    Lister JJ; Lister HH
    Rural Remote Health; 2021 Nov; 21(4):6770. PubMed ID: 34757760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between buprenorphine provider availability and opioid deaths among US counties.
    Jones CW; Christman Z; Smith CM; Safferman MR; Salzman M; Baston K; Haroz R
    J Subst Abuse Treat; 2018 Oct; 93():19-25. PubMed ID: 30126537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.
    Leiner C; Cody T; Mullins N; Ramage M; Ostrach BMM
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):143. PubMed ID: 33596843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A qualitative study of rural healthcare providers' views of social, cultural, and programmatic barriers to healthcare access.
    Coombs NC; Campbell DG; Caringi J
    BMC Health Serv Res; 2022 Apr; 22(1):438. PubMed ID: 35366860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States.
    Kiang MV; Barnett ML; Wakeman SE; Humphreys K; Tsai AC
    Drug Alcohol Depend; 2021 Nov; 228():109081. PubMed ID: 34600256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming Barriers: Individual Experiences Obtaining Medication-Assisted Treatment for Opioid Use Disorder.
    Scorsone KL; Haozous EA; Hayes L; Cox KJ
    Qual Health Res; 2020 Nov; 30(13):2103-2117. PubMed ID: 32691670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment.
    Titus-Glover D; Shaya FT; Welsh C; Qato DM; Shah S; Gresssler LE; Vivrette R
    BMC Health Serv Res; 2021 Mar; 21(1):215. PubMed ID: 33691677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
    Andrilla CHA; Coulthard C; Larson EH
    Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breastfeeding in Women on Opioid Maintenance Therapy: A Review of Policy and Practice.
    Clark RRS
    J Midwifery Womens Health; 2019 Sep; 64(5):545-558. PubMed ID: 31294522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018.
    Conway KP; Khoury D; Hilscher R; Aldridge AP; Parker SJ; Zarkin GA
    Addict Sci Clin Pract; 2022 Jan; 17(1):5. PubMed ID: 35101112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 40. Identifying Provider Barriers to the Implementation of Opioid Harm Reduction Methods: An Initial Narrative Review.
    Dee SA; Delonnay KA; Bernard D; Jean-Baptiste F
    Inquiry; 2024; 61():469580241276144. PubMed ID: 39313923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.